PT Borden Eagle Indonesia (Indonesia)

Borden Eagle Indonesia is primarily engaged in pharmaceuticals activity. Its headquarters is located in Banten. The company was founded in 2018. Borden Eagle Indonesia is a dynamic player in the Indonesian pharmaceutical industry, focusing on the development, manufacturing, and distribution of high-quality pharmaceutical products. The company was founded by a team of experienced professionals in the pharmaceutical sector, aiming to address the growing healthcare needs in Indonesia. The primary business line of Borden Eagle Indonesia is pharmaceuticals, with a secondary focus on healthcare solutions and medical supplies. The company has established a strong local presence with several branches across major cities in Indonesia, including Jakarta, Surabaya, and Medan, ensuring widespread distribution and accessibility of its products. Borden Eagle Indonesia offers a diverse range of pharmaceutical products, including generic medicines, over-the-counter drugs, and specialized healthcare solutions. The company is committed to innovation and quality, with a dedicated research and development team working on new formulations and therapies. While the company primarily operates within Indonesia, it has plans to expand its footprint to neighboring Southeast Asian countries, exploring potential export markets in Malaysia, Thailand, and Vietnam. Borden Eagle Indonesia collaborates with various local healthcare providers and international pharmaceutical companies to enhance its product offerings and market reach. The company is a member of several industry associations, including the Indonesian Pharmaceutical Association, which helps it stay updated with industry trends and regulatory changes. Borden Eagle Indonesia is dedicated to improving public health and aims to become a leading pharmaceutical company in the region, driven by its mission to provide affordable and effective healthcare solutions to all.